Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000335012 | SCV000339055 | uncertain significance | not provided | 2016-01-21 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001335215 | SCV001528309 | uncertain significance | Niemann-Pick disease, type C1 | 2018-04-18 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Labcorp Genetics |
RCV001335215 | SCV002968090 | uncertain significance | Niemann-Pick disease, type C1 | 2022-08-19 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 156 of the NPC1 protein (p.Met156Thr). This variant is present in population databases (rs147615070, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of NPC1-related conditions (PMID: 25497598). ClinVar contains an entry for this variant (Variation ID: 285856). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C25"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |